ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

SMMT Summit Therapeutics Inc

4,4254
0,0354 (0,81%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Summit Therapeutics Inc SMMT NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,0354 0,81% 4,4254 14:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,39
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202413:00BWSummit Therapeutics Reports Financial Results and..
24.4.202422:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
11.4.202422:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
10.4.202413:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
22.3.202412:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
14.3.202412:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
05.3.202422:05EDGAR2Form 8-K - Current report
05.3.202413:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
20.2.202414:05EDGAR2Form 8-K - Current report
20.2.202413:55EDGAR2Form S-3 - Registration statement under Securities Act of..
20.2.202413:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20.2.202413:00BWSummit Therapeutics Reports Financial Results and..
15.2.202423:25EDGAR2Form 8-K - Current report
14.2.202422:35EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
14.2.202416:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
14.2.202413:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
07.2.202413:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
08.1.202415:07EDGAR2Form 8-K - Current report
08.1.202415:00BWSummit Therapeutics Announces Updated Phase II Data for..
04.1.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:06EDGAR2Form 8-K - Current report
03.1.202413:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
13.12.202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202314:03EDGAR2Form 8-K - Current report
07.11.202313:00BWSummit Therapeutics Reports Financial Results and..
02.11.202321:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
31.10.202321:02EDGAR2Form 8-K - Current report
31.10.202313:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
26.10.202314:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
19.10.202314:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
16.10.202313:46EDGAR2Form 8-K - Current report
16.10.202313:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
19.9.202321:40EDGAR2Form DEF 14A - Other definitive proxy statements
08.9.202322:08EDGAR2Form PRE 14A - Other preliminary proxy statements
09.8.202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202314:03EDGAR2Form 8-K - Current report
09.8.202313:00BWSummit Therapeutics Reports Financial Results and..
02.8.202322:05EDGAR2Form 8-K - Current report
02.8.202314:00BWSummit Therapeutics to Host Q2 2023 Financial Results &..
04.6.202314:00BWPromising Data for Investigational Innovative Bispecific..
01.6.202313:30BWIvonescimab Updated Data to be Featured at ASCO 2023
11.5.202313:30BWSummit Therapeutics Reports Financial Results and..
09.5.202313:30BWSummit Therapeutics Announces First Patient Treated in Phase..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock